|21st November 2018
BLH speaks to Nicole Huyghe, founder and Managing Director of data science consultancy Boobook, about the growing need from businesses for data-driven decision making.
NH: With the customer analytics side of the business, our clients ask us to analyse data provided by their customers to make an informed decision. We analyse the data and translate it into strategic insights.
The second part is personalisation and that has different components. The analysis gives us lots of interesting numbers and we have to make sure we translate it into a story, which is relevant for the business.
How we do this is equally important as the numbers are often difficult to interpret. We produce very powerful visuals – charts, PowerPoint presentations and dashboards – so that clients can look at the data from different perspectives, in a way that is easy to understand and act upon.
"We analyse the data and translate it into strategic insights"
Most challenges are related to what we call customer segmentation. Companies want to know how they best approach the different types of customer they have. We ask the question: “How do we approach different types of customers in the best way?” This is done by identifying customer needs and underlying motivations so that people are targeted with the right messages and products. We then identify the needs and target people so that they’re more susceptible to our messages.
We also work on product development. This involves supporting companies by advising them on what their new or optimised product or service should look like. We look at the kind of features that benefit consumers and trigger their interest.
|16th August 2019
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to make a more accurate treatment decision. Here we discuss the barriers, opportunities and potential outcomes of the precision medicine era in healthcare.
|26th July 2019
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist and Director of Public Health at Genomics England, to find out how the NHS is achieving this goal.
|16th July 2019
The number of mental health research programmes in larger drug firms has shrunk by 70% in the past decade. Blue Latitude Health Senior Associate Consultant Sana Rahim explores this drop in investment and explains why developing a market-orientated model is vital for making progress.